{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:38:20Z","timestamp":1784255900046,"version":"3.55.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s40257-023-00821-4","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T18:02:31Z","timestamp":1698688951000},"page":"55-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2227-2993","authenticated-orcid":false,"given":"M\u00f3nica","family":"Munera-Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-0771","authenticated-orcid":false,"given":"Jose Manuel","family":"Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"821_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1385\/CRIAI:26:3:161","volume":"26","author":"JA Poole","year":"2004","unstructured":"Poole JA, Claman HN. Immunology of pregnancy. Implications for the mother. Clin Rev Allergy Immunol. 2004;26:161\u201370.","journal-title":"Clin Rev Allergy Immunol"},{"key":"821_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.gde.2017.08.004","volume":"47","author":"AR Chavan","year":"2017","unstructured":"Chavan AR, Griffith OW, Wagner GP. The inflammation paradox in the evolution of mammalian pregnancy: turning a foe into a friend. Curr Opin Genet Dev. 2017;47:24\u201332.","journal-title":"Curr Opin Genet Dev"},{"key":"821_CR3","doi-asserted-by":"crossref","unstructured":"Kanda N, Hoashi T, Saeki H. The roles of sex hormones in the course of atopic dermatitis. Int J Mol Sci. 2019;20(19):4660.","DOI":"10.3390\/ijms20194660"},{"key":"821_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fendo.2014.00106","volume":"5","author":"B Polese","year":"2014","unstructured":"Polese B, Gridelet V, Araklioti E, Martens H, Perrier d\u2019Hauterive S, Geenen V. The endocrine milieu and CD4 T-lymphocyte polarization during pregnancy. Front Endocrinol (Lausanne). 2014;5:106.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"821_CR5","doi-asserted-by":"publisher","first-page":"A502","DOI":"10.1016\/j.autrev.2011.12.003","volume":"11","author":"GC Hughes","year":"2012","unstructured":"Hughes GC. Progesterone and autoimmune disease. Autoimmun Rev. 2012;11:A502\u201314.","journal-title":"Autoimmun Rev"},{"key":"821_CR6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.4049\/jimmunol.168.3.1087","volume":"168","author":"H Miyaura","year":"2002","unstructured":"Miyaura H, Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol. 2002;168:1087\u201394.","journal-title":"J Immunol"},{"key":"821_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/120347540200600308","volume":"6","author":"B Barankin","year":"2002","unstructured":"Barankin B, Silver SG, Carruthers A. The skin in pregnancy. J Cutan Med Surg. 2002;6:236\u201340.","journal-title":"J Cutan Med Surg"},{"key":"821_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.clindermatol.2016.02.002","volume":"34","author":"M Danesh","year":"2016","unstructured":"Danesh M, Pomeranz MK, McMeniman E, Murase JE. Dermatoses of pregnancy: nomenclature, misnomers, and myths. Clin Dermatol. 2016;34:314\u20139.","journal-title":"Clin Dermatol"},{"key":"821_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000515600","volume":"238","author":"A Horev","year":"2022","unstructured":"Horev A, Shalom G, Weintraub AY, Freud T, Cohen AD. Atopic dermatitis and infertility: a nationwide retrospective cohort study. Dermatology. 2022;238:313\u20139.","journal-title":"Dermatology"},{"key":"821_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.det.2017.02.002","volume":"35","author":"JI Silverberg","year":"2017","unstructured":"Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35:283\u20139.","journal-title":"Dermatol Clin"},{"key":"821_CR11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"S Barbarot","year":"2018","unstructured":"Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73:1284\u201393.","journal-title":"Allergy"},{"key":"821_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12958-015-0032-1","volume":"13","author":"A Agarwal","year":"2015","unstructured":"Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015;13:37.","journal-title":"Reprod Biol Endocrinol"},{"key":"821_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.fertnstert.2005.02.053","volume":"84","author":"M Arslan","year":"2005","unstructured":"Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil Steril. 2005;84:555\u201369.","journal-title":"Fertil Steril"},{"key":"821_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13389","volume":"85","author":"R Finelli","year":"2021","unstructured":"Finelli R, Leisegang K, Finocchi F, De Masi S, Agarwal A, Damiani G. The impact of autoimmune systemic inflammation and associated medications on male reproductive health in patients with chronic rheumatological, dermatological, and gastroenterological diseases: a systematic review. Am J Reprod Immunol. 2021;85: e13389.","journal-title":"Am J Reprod Immunol"},{"key":"821_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/JAA.S203576","volume":"12","author":"J Bl\u00e1foss","year":"2019","unstructured":"Bl\u00e1foss J, Hansen AV, Malchau Lauesgaard SS, Ali Z, Ulrik CS. Female asthma and atopy\u2014impact on fertility: a systematic review. J Asthma Allergy. 2019;12:205\u201311.","journal-title":"J Asthma Allergy"},{"key":"821_CR16","first-page":"1314","volume":"11","author":"L Linares-Gonzalez","year":"2021","unstructured":"Linares-Gonzalez L, Lozano-Lozano I, Gutierrez-Rojas L, Lozano-Lozano M, Rodenas-Herranz T, Ruiz-Villaverde R. Sexual dysfunction and atopic dermatitis: a systematic review. Life (Basel, Switzerland). 2021;11(12):1314.","journal-title":"Life (Basel, Switzerland)."},{"key":"821_CR17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1183\/09031936.00148713","volume":"43","author":"EJ Gade","year":"2014","unstructured":"Gade EJ, Thomsen SF, Lindenberg S, Kyvik KO, Lieberoth S, Backer V. Asthma affects time to pregnancy and fertility: a register-based twin study. Eur Respir J. 2014;43:1077\u201385.","journal-title":"Eur Respir J"},{"key":"821_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1365-2222.2005.02300.x","volume":"35","author":"J Sunyer","year":"2005","unstructured":"Sunyer J, Ant\u00f3 JM, Plana E, Janson C, Jarvis D, Kony S, et al. Maternal atopy and changes in parity. Clin Exp Allergy. 2005;35:1028\u201332.","journal-title":"Clin Exp Allergy"},{"key":"821_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1046\/j.0905-6157.2003.00089.x","volume":"14","author":"W Karmaus","year":"2003","unstructured":"Karmaus W, Eneli I. Maternal atopy and the number of offspring: is there an association? Pediatr Allergy Immunol. 2003;14:470\u20134.","journal-title":"Pediatr Allergy Immunol"},{"key":"821_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1399-3038.1997.tb00166.x","volume":"8","author":"L Nilsson","year":"1997","unstructured":"Nilsson L, Kjellman NI, L\u00f6fman O, Bj\u00f6rkst\u00e9n B. Parity among atopic and non-atopic mothers. Pediatr Allergy Immunol. 1997;8:134\u20136.","journal-title":"Pediatr Allergy Immunol"},{"key":"821_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/aje\/kwk092","volume":"165","author":"LJ Tata","year":"2007","unstructured":"Tata LJ, Hubbard RB, McKeever TM, Smith CJP, Doyle P, Smeeth L, et al. Fertility rates in women with asthma, eczema, and hay fever: a general population-based cohort study. Am J Epidemiol. 2007;165:1023\u201330.","journal-title":"Am J Epidemiol"},{"key":"821_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","volume":"40","author":"J Kim","year":"2019","unstructured":"Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc. 2019;40:84\u201392.","journal-title":"Allergy Asthma Proc"},{"key":"821_CR23","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1007\/s43032-021-00721-0","volume":"29","author":"S Dutta","year":"2022","unstructured":"Dutta S, Sandhu N, Sengupta P, Alves MG, Henkel R, Agarwal A. Somatic-immune cells crosstalk in-the-making of testicular immune privilege. Reprod Sci. 2022;29:2707\u201318.","journal-title":"Reprod Sci"},{"key":"821_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.alit.2021.11.006","volume":"71","author":"T Yoshida","year":"2022","unstructured":"Yoshida T, Beck LA, De Benedetto A. Skin barrier defects in atopic dermatitis: from old idea to new opportunity. Allergol Int. 2022;71:3\u201313.","journal-title":"Allergol Int"},{"key":"821_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161759","volume":"11","author":"T Yuki","year":"2016","unstructured":"Yuki T, Tobiishi M, Kusaka-Kikushima A, Ota Y, Tokura Y. Impaired tight junctions in atopic dermatitis skin and in a skin-equivalent model treated with interleukin-17. PLoS ONE. 2016;11: e0161759.","journal-title":"PLoS ONE"},{"key":"821_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.17772\/gp\/1546","volume":"84","author":"M Miko\u0142ajczyk","year":"2013","unstructured":"Miko\u0142ajczyk M, Wirstlein P, Skrzypczak J. Aberrant claudin-4 transcript levels in eutopic endometrium of women with idiopathic infertility and minimal endometriosis. Ginekol Pol. 2013;84:90\u20134.","journal-title":"Ginekol Pol"},{"key":"821_CR27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4103\/1008-682X.163189","volume":"18","author":"MJ McCabe","year":"2016","unstructured":"McCabe MJ, Foo CF, Dinger ME, Smooker PM, Stanton PG. Claudin-11 and occludin are major contributors to Sertoli cell tight junction function, in vitro. Asian J Androl. 2016;18:620\u20136.","journal-title":"Asian J Androl"},{"key":"821_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/09513590802242694","volume":"24","author":"R Gaetje","year":"2008","unstructured":"Gaetje R, Holtrich U, Engels K, Kissler S, Rody A, Karn T, et al. Differential expression of claudins in human endometrium and endometriosis. Gynecol Endocrinol. 2008;24:442\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"821_CR29","doi-asserted-by":"publisher","first-page":"100123","DOI":"10.1016\/j.xjidi.2022.100123","volume":"2","author":"JS Barbieri","year":"2022","unstructured":"Barbieri JS, Shin DB, Margolis DJ. Atopic dermatitis is associated with preeclampsia and endometriosis. JID Innov. 2022;2:100123.","journal-title":"JID Innov."},{"key":"821_CR30","first-page":"221","volume":"24","author":"X-F Yang","year":"2018","unstructured":"Yang X-F, Fu C, Liu Y-Q, Liu R-S, Feng H, Huang R-Y, et al. Expression of CLAUDIN-11 in the testicular tissue of the patient with non-obstructive azoospermia and its clinical significance. Zhonghua Nan Ke Xue. 2018;24:221\u20135.","journal-title":"Zhonghua Nan Ke Xue"},{"key":"821_CR31","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jaad.2017.05.025","volume":"77","author":"BY Kong","year":"2017","unstructured":"Kong BY, Immaneni S, Paller AS, Xu S. Potential impact of biologics and emerging therapies for psoriasis and atopic dermatitis on future fertility: reassurance to patients but more data are needed. J Am Acad Dermatol. 2017;77(4):758\u201363.","journal-title":"J Am Acad Dermatol"},{"key":"821_CR32","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cmi.2017.04.020","volume":"23","author":"A Roca","year":"2017","unstructured":"Roca A, Bojang A, Camara B, Oluwalana C, Lette K, West P, et al. Maternal colonization with Staphylococcus aureus and Group B streptococcus is associated with colonization in newborns. Clin Microbiol Infect. 2017;23:974\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"821_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/jdv.15256","volume":"33","author":"CR Hamann","year":"2019","unstructured":"Hamann CR, Egeberg A, Wollenberg A, Gislason G, Skov L, Thyssen JP. Pregnancy complications, treatment characteristics and birth outcomes in women with atopic dermatitis in Denmark. J Eur Acad Dermatol Venereol. 2019;33:577\u201387.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"821_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri.2017.64","volume":"17","author":"G Mor","year":"2017","unstructured":"Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017;17:469\u201382.","journal-title":"Nat Rev Immunol"},{"key":"821_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1530\/REP-14-0395","volume":"149","author":"Y Gnainsky","year":"2015","unstructured":"Gnainsky Y, Granot I, Aldo P, Barash A, Or Y, Mor G, et al. Biopsy-induced inflammatory conditions improve endometrial receptivity: the mechanism of action. Reproduction. 2015;149:75\u201385.","journal-title":"Reproduction"},{"key":"821_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fimmu.2015.00321","volume":"6","author":"AC Zenclussen","year":"2015","unstructured":"Zenclussen AC, H\u00e4mmerling GJ. Cellular regulation of the uterine microenvironment that enables embryo implantation. Front Immunol. 2015;6:321.","journal-title":"Front Immunol"},{"key":"821_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","volume":"63","author":"S Saito","year":"2010","unstructured":"Saito S, Nakashima A, Shima T, Ito M. Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63:601\u201310.","journal-title":"Am J Reprod Immunol"},{"key":"821_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1530\/rep.1.00197","volume":"130","author":"TM Lindstr\u00f6m","year":"2005","unstructured":"Lindstr\u00f6m TM, Bennett PR. The role of nuclear factor kappa B in human labour. Reproduction. 2005;130:569\u201381.","journal-title":"Reproduction"},{"key":"821_CR39","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/all.14131","volume":"75","author":"W Grobe","year":"2020","unstructured":"Grobe W, Peng W, Allam J-P, Yu C-F, Novak N. Androgens have an anti-inflammatory effect on human basophils in vitro. Allergy. 2020;75(4):992\u20134.","journal-title":"Allergy"},{"key":"821_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yhbeh.2016.11.017","volume":"88","author":"J Roved","year":"2017","unstructured":"Roved J, Westerdahl H, Hasselquist D. Sex differences in immune responses: hormonal effects, antagonistic selection, and evolutionary consequences. Horm Behav. 2017;88:95\u2013105.","journal-title":"Horm Behav"},{"key":"821_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5021\/ad.2010.22.2.180","volume":"22","author":"S Cho","year":"2010","unstructured":"Cho S, Kim HJ, Oh SH, Park CO, Jung JY, Lee KH. The influence of pregnancy and menstruation on the deterioration of atopic dermatitis symptoms. Ann Dermatol. 2010;22:180\u20135.","journal-title":"Ann Dermatol"},{"key":"821_CR42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaad.2005.12.012","volume":"54","author":"CM Ambros-Rudolph","year":"2006","unstructured":"Ambros-Rudolph CM, M\u00fcllegger RR, Vaughan-Jones SA, Kerl H, Black MM. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006;54:395\u2013404.","journal-title":"J Am Acad Dermatol"},{"key":"821_CR43","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/OGX.0b013e31823a0908","volume":"66","author":"I Koutroulis","year":"2011","unstructured":"Koutroulis I, Papoutsis J, Kroumpouzos G. Atopic dermatitis in pregnancy: current status and challenges. Obstet Gynecol Surv. 2011;66:654\u201363.","journal-title":"Obstet Gynecol Surv"},{"key":"821_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1365-2133.1999.02923.x","volume":"141","author":"SA Vaughan Jones","year":"1999","unstructured":"Vaughan Jones SA, Hern S, Nelson-Piercy C, Seed PT, Black MM. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol. 1999;141:71\u201381.","journal-title":"Br J Dermatol"},{"key":"821_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40257-021-00668-7","volume":"23","author":"AA Stefaniak","year":"2022","unstructured":"Stefaniak AA, Pereira MP, Zeidler C, St\u00e4nder S. Pruritus in pregnancy. Am J Clin Dermatol. 2022;23:231\u201346.","journal-title":"Am J Clin Dermatol"},{"key":"821_CR46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2222.2004.1928.x","volume":"34","author":"Y-C Lin","year":"2004","unstructured":"Lin Y-C, Wen H-J, Lee Y-L, Guo YL. Are maternal psychosocial factors associated with cord immunoglobulin E in addition to family atopic history and mother immunoglobulin E? Clin Exp Allergy. 2004;34:548\u201354.","journal-title":"Clin Exp Allergy"},{"key":"821_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-3016.2009.01092.x","volume":"24","author":"MO L\u00f8ken","year":"2010","unstructured":"L\u00f8ken MO, Jeansson S, Jenum PA, Eskild A. Serum level of immunoglobulin E during pregnancy\u2014does offspring sex matter? Paediatr Perinat Epidemiol. 2010;24:75\u20138.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"821_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1365-2133.1994.tb08530.x","volume":"131","author":"HC Williams","year":"1994","unstructured":"Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The U.K. Working Party\u2019s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994;131:383\u201396.","journal-title":"Br J Dermatol"},{"key":"821_CR49","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.clindermatol.2016.02.012","volume":"34","author":"MM Roth","year":"2016","unstructured":"Roth MM, Cristodor P, Kroumpouzos G. Prurigo, pruritic folliculitis, and atopic eruption of pregnancy: facts and controversies. Clin Dermatol. 2016;34:392\u2013400.","journal-title":"Clin Dermatol"},{"key":"821_CR50","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaci.2022.01.010","volume":"149","author":"G Balakirski","year":"2022","unstructured":"Balakirski G, Novak N. Atopic dermatitis and pregnancy. J Allergy Clin Immunol. 2022;149:1185\u201394.","journal-title":"J Allergy Clin Immunol"},{"key":"821_CR51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1365-2133.2005.06856.x","volume":"154","author":"CM Rudolph","year":"2006","unstructured":"Rudolph CM, Al-Fares S, Vaughan-Jones SA, M\u00fcllegger RR, Kerl H, Black MM. Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients. Br J Dermatol. 2006;154:54\u201360.","journal-title":"Br J Dermatol"},{"issue":"63","key":"821_CR52","first-page":"67","volume":"58","author":"S Regnier","year":"2008","unstructured":"Regnier S, Fermand V, Levy P, Uzan S, Aractingi S. A case-control study of polymorphic eruption of pregnancy. J Am Acad Dermatol. 2008;58(63):67.","journal-title":"J Am Acad Dermatol"},{"key":"821_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2020.11.076","volume":"85","author":"CM Montagnon","year":"2021","unstructured":"Montagnon CM, Tolkachjov SN, Murrell DF, Camilleri MJ, Lehman JS. Subepithelial autoimmune blistering dermatoses: clinical features and diagnosis. J Am Acad Dermatol. 2021;85:1\u201314.","journal-title":"J Am Acad Dermatol"},{"key":"821_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0002-9378(16)34138-2","volume":"104","author":"RC Kolodny","year":"1969","unstructured":"Kolodny RC. Herpes gestationis. A new assessment of incidence, diagnosis, and fetal prognosis. Am J Obstet Gynecol. 1969;104:39\u201345.","journal-title":"Am J Obstet Gynecol"},{"key":"821_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijwd.2016.11.004","volume":"3","author":"Z Hallaji","year":"2017","unstructured":"Hallaji Z, Mortazavi H, Ashtari S, Nikoo A, Abdollahi M, Nasimi M. Pemphigoid gestationis: clinical and histologic features of twenty-three patients. Int J Womens Dermatol. 2017;3:86\u201390.","journal-title":"Int J Womens Dermatol"},{"key":"821_CR56","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejogrb.2018.10.041","volume":"231","author":"MJ Bicocca","year":"2018","unstructured":"Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol. 2018;231:180\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"821_CR57","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/jdv.15709","volume":"33","author":"C Vestergaard","year":"2019","unstructured":"Vestergaard C, Wollenberg A, Barbarot S, Christen-Zaech S, Deleuran M, Spuls P, et al. European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. J Eur Acad Dermatol Venereol. 2019;33:1644\u201359.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"821_CR58","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/PL00002604","volume":"52","author":"R Niedner","year":"2001","unstructured":"Niedner R. Therapy with systemic glucocorticoids. Hautarzt. 2001;52:1062\u20134.","journal-title":"Hautarzt"},{"key":"821_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2133.1989.tb01396.x","volume":"121","author":"S Coopman","year":"1989","unstructured":"Coopman S, Degreef H, Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol. 1989;121:27\u201334.","journal-title":"Br J Dermatol"},{"key":"821_CR60","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1365-2133.2011.10513.x","volume":"165","author":"C-C Chi","year":"2011","unstructured":"Chi C-C, Kirtschig G, Aberer W, Gabbud J-P, Lipozen\u010di\u0107 J, K\u00e1rp\u00e1ti S, et al. Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol. 2011;165:943\u201352.","journal-title":"Br J Dermatol"},{"key":"821_CR61","doi-asserted-by":"crossref","unstructured":"Chi C-C, Wang S-H, Wojnarowska F, Kirtschig G, Davies E, Bennett C. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2015(10); p. CD007346.","DOI":"10.1002\/14651858.CD007346.pub3"},{"key":"821_CR62","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1097\/00007890-200012270-00010","volume":"70","author":"A Kainz","year":"2000","unstructured":"Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation. 2000;70:1718\u201321.","journal-title":"Transplantation"},{"key":"821_CR63","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jaad.2005.06.013","volume":"53","author":"Z Draelos","year":"2005","unstructured":"Draelos Z, Nayak A, Pariser D, Shupack JL, Chon K, Abrams B, et al. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison. J Am Acad Dermatol. 2005;53:602\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"821_CR64","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1365-2133.2008.08974.x","volume":"160","author":"NA Undre","year":"2009","unstructured":"Undre NA, Moloney FJ, Ahmadi S, Stevenson P, Murphy GM. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol. 2009;160:665\u20139.","journal-title":"Br J Dermatol"},{"key":"821_CR65","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2147\/CCID.S87987","volume":"8","author":"A Patrizi","year":"2015","unstructured":"Patrizi A, Raone B, Ravaioli GM. Management of atopic dermatitis: safety and efficacy of phototherapy. Clin Cosmet Investig Dermatol. 2015;8:511\u201320.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"821_CR66","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jaad.2016.10.016","volume":"77","author":"M Zhang","year":"2017","unstructured":"Zhang M, Goyert G, Lim HW. Folate and phototherapy: what should we inform our patients? J Am Acad Dermatol. 2017;77:958\u201364.","journal-title":"J Am Acad Dermatol"},{"key":"821_CR67","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa071453","volume":"357","author":"RJ Wapner","year":"2007","unstructured":"Wapner RJ, Sorokin Y, Mele L, Johnson F, Dudley DJ, Spong CY, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357:1190\u20138.","journal-title":"N Engl J Med"},{"key":"821_CR68","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-2003-40605","volume":"20","author":"S-OS Chin","year":"2003","unstructured":"Chin S-OS, Brodsky NL, Bhandari V. Antenatal steroid use is associated with increased gastroesophageal reflux in neonates. Am J Perinatol. 2003;20:205\u201313.","journal-title":"Am J Perinatol"},{"key":"821_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.reprotox.2008.05.053","volume":"26","author":"C Weber-Schoendorfer","year":"2008","unstructured":"Weber-Schoendorfer C, Schaefer C. The safety of cetirizine during pregnancy. A prospective observational cohort study. Reprod Toxicol. 2008;26:19\u201323.","journal-title":"Reprod Toxicol"},{"key":"821_CR70","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1067\/mai.2003.130","volume":"111","author":"ME Moretti","year":"2003","unstructured":"Moretti ME, Caprara D, Coutinho CJ, Bar-Oz B, Berkovitch M, Addis A, et al. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin Immunol. 2003;111:479\u201383.","journal-title":"J Allergy Clin Immunol"},{"key":"821_CR71","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jaad.2010.02.062","volume":"63","author":"C Ryan","year":"2010","unstructured":"Ryan C, Amor KT, Menter A. The use of cyclosporine in dermatology: part II. J Am Acad Dermatol. 2010;63:944\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"821_CR72","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","volume":"71","author":"B Bar Oz","year":"2001","unstructured":"Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71:1051\u20135.","journal-title":"Transplantation"},{"key":"821_CR73","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3109\/14767058.2011.634461","volume":"25","author":"A Perales-Puchalt","year":"2012","unstructured":"Perales-Puchalt A, Vila Vives JM, L\u00f3pez Montes J, Diago Almela VJ, Perales A. Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison. J Matern Fetal Neonatal Med. 2012;25:1363\u20136.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"821_CR74","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","volume":"67","author":"Y-SC Bae","year":"2012","unstructured":"Bae Y-SC, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M, et al. Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012;67:459\u201377.","journal-title":"J Am Acad Dermatol"},{"key":"821_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ibd.22948","volume":"19","author":"M Akbari","year":"2013","unstructured":"Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:15\u201322.","journal-title":"Inflamm Bowel Dis"},{"key":"821_CR76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09546634.2016.1202402","volume":"30","author":"SM Brown","year":"2019","unstructured":"Brown SM, Aljefri K, Waas R, Hampton P. Systemic medications used in treatment of common dermatological conditions: safety profile with respect to pregnancy, breast feeding and content in seminal fluid. J Dermatolog Treat. 2019;30:2\u201318.","journal-title":"J Dermatolog Treat"},{"key":"821_CR77","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C G\u00f6testam Skorpen","year":"2016","unstructured":"G\u00f6testam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795\u2013810.","journal-title":"Ann Rheum Dis"},{"key":"821_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14475","volume":"34","author":"M Napolitano","year":"2021","unstructured":"Napolitano M, Ruggiero A, Fontanella G, Fabbrocini G, Patruno C. New emergent therapies for atopic dermatitis: a review of safety profile with respect to female fertility, pregnancy, and breastfeeding. Dermatol Ther. 2021;34: e14475.","journal-title":"Dermatol Ther"},{"key":"821_CR79","doi-asserted-by":"publisher","first-page":"1759720X1989929","DOI":"10.1177\/1759720X19899296","volume":"12","author":"G Costanzo","year":"2020","unstructured":"Costanzo G, Firinu D, Losa F, Deidda M, Barca MP, Del Giacco S. Baricitinib exposure during pregnancy in rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2020;12:1759720X19899296.","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"821_CR80","unstructured":"Annex I. EU Summ Prod Charact Available https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/olumiant-epar-product-information_en.pdf [Internet]. 1994;20:338\u201340. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/olumiant-epar-product-information_en.pdf"},{"key":"821_CR81","unstructured":"(Upadacitinib). EU. Summary of Product Characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/rinvoq-epar-product-information_en.pdf. Accessed 01 Sep 2023"},{"key":"821_CR82","unstructured":"(Abrocitinib). EU. Summary of Product Characteristics. \/https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cibinqo-epar-product-information_en.pdf. Accessed 01 Sep 2023"},{"issue":"6","key":"821_CR83","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/jdv.18922","volume":"37","author":"DN Adam","year":"2023","unstructured":"Adam DN, Gooderham MJ, Beecker JR, Hong CH, Jack CS, Jain V, et al. J Eur Acad Dermatol Venereol. 2023;37(6):1135\u201348.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"821_CR84","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/all.14282","volume":"76","author":"B Pfaller","year":"2021","unstructured":"Pfaller B, Jos\u00e9 Yepes-Nu\u00f1ez J, Agache I, Akdis CA, Alsalamah M, Bavbek S, et al. Biologicals in atopic disease in pregnancy: an EAACI position paper. Allergy Denmark. 2021;76:71\u201389.","journal-title":"Allergy. Denmark"},{"key":"821_CR85","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.iac.2022.07.001","volume":"43","author":"LC Ramos","year":"2023","unstructured":"Ramos LC, Namazy J. Monoclonal antibodies (biologics) for allergic rhinitis, asthma, and atopic dermatitis during pregnancy and lactation. Immunol Allergy Clin N Am. 2023;43:187\u201397.","journal-title":"Immunol Allergy Clin N Am."},{"key":"821_CR86","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.waojou.2022.100737","volume":"16","author":"AN Sitek","year":"2023","unstructured":"Sitek AN, Li JT, Pongdee T. Risks and safety of biologics: a practical guide for allergists. World Allergy Organ J. 2023;16:100737.","journal-title":"World Allergy Organ J"},{"key":"821_CR87","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1016\/j.jaip.2022.08.013","volume":"10","author":"F Shakuntulla","year":"2022","unstructured":"Shakuntulla F, Chiarella SE. Safety of biologics for atopic diseases during pregnancy. J Allergy Clin Immunol Pract. 2022;10:3149\u201355.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"821_CR88","first-page":"5448","volume":"25","author":"R Khamisy-Farah","year":"2021","unstructured":"Khamisy-Farah R, Damiani G, Kong JD, Wu J-H, Bragazzi NL. Safety profile of dupilumab during pregnancy: a data mining and disproportionality analysis of over 37,000 reports from the WHO individual case safety reporting database (VigiBaseTM). Eur Rev Med Pharmacol Sci Italy. 2021;25:5448\u201351.","journal-title":"Eur Rev Med Pharmacol Sci. Italy"},{"key":"821_CR89","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1159\/000515246","volume":"13","author":"Y Lobo","year":"2021","unstructured":"Lobo Y, Lee RC, Spelman L. Atopic dermatitis treated safely with dupilumab during pregnancy: a case report and review of the literature. Case Rep Dermatol. 2021;13(2):248\u201356.","journal-title":"Case Rep Dermatol"},{"key":"821_CR90","doi-asserted-by":"crossref","unstructured":"Escol\u00e0 H, Figueras-Nart I, Bonfill-Orti M, Coll Puigserver N, Martin-Santiago A, Rodr\u00edguez Serna M, et al. Dupilumab for atopic dermatitis during pregnancy and breastfeeding: clinical experience in 13 patients. J Eur Acad Dermatol Venereol. 2023;37(9):e1156-60","DOI":"10.1111\/jdv.19165"},{"key":"821_CR91","doi-asserted-by":"publisher","first-page":"120347542311522","DOI":"10.1177\/12034754231152223","volume":"27","author":"E Akuffo-Addo","year":"2023","unstructured":"Akuffo-Addo E, Nicholas MN, Lansang P. Reported pregnancy outcomes in women with severe atopic dermatitis treated with dupilumab: a systematic review. J Cutan Med Surg. 2023;27(2):177\u2013178.","journal-title":"J Cutan Med Surg"},{"key":"821_CR92","doi-asserted-by":"publisher","first-page":"1901208","DOI":"10.1183\/13993003.01208-2019","volume":"55","author":"PG Middleton","year":"2020","unstructured":"Middleton PG, Gade EJ, Aguilera C, MacKillop L, Button BM, Coleman C, et al. ERS\/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur Respir J. 2020;55(2):1901208.","journal-title":"Eur Respir J"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00821-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-023-00821-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00821-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T21:45:50Z","timestamp":1705614350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-023-00821-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1007\/s40257-023-00821-4","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"9 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors received no funding for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"M. Munera-Campos has received fees for scientific advisory, presentations, and other related activities from AbbVie, LEO\u00a0Pharma, Janssen, Sanofi, and Galderma. She has also participated as a principal investigator and sub-investigator in clinical trials for Lilly, LEO\u00a0Pharma, Novartis, Janssen, Sanofi, Pfizer, AbbVie, Almirall, UCB, and Galderma. J.M. Carrascosa has participated as a principal investigator\/sub-investigator and has received fees as a speaker or as a member of the expert steering committee for AbbVie, Novartis, Janssen, Lilly, Sandoz, Amgen, Almirall, BMS, Boehringer Ingelheim, Biogen, LEO\u00a0Pharma, and UCB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent to Participate\/Publish"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"MM-C and JMC have equally participated in the critical literature review and the writing of this manuscript. All authors have read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}